AICAR Supplier China: 50mg Wholesale COA Guide

Classify AICAR correctly before requesting a quote

Write the controlled name AICAR or Acadesine, the complete chemical name or authoritative molecular reference, CAS number where applicable, molecular formula and molecular weight, physical form, requested strength, quantity and Research Use Only status. Record AICA riboside as a controlled synonym only after identity is confirmed. Do not ask for an amino-acid sequence or accept a peptide-only specification template. Require the quotation, specification, COA, analytical files, vial label and packing list to use one traceable product code and chemical identity.

Define the 50mg presentation and quote basis

Record the 50mg strength, vial count, units per kit, total nominal AICAR, content tolerance, parent lot, finished lot, packaging and price denominator. If a supplier proposes another strength or a bulk-powder format, treat it as a separate SKU requiring explicit technical and commercial review rather than an equivalent substitute. Clarify whether MOQ applies per vial, kit, lot or order and prohibit unreviewed format changes. Compare offers using total documented target compound, equivalent test scope and packaging rather than box or vial price alone.

Use chemical identity methods instead of a peptide shortcut

Request batch-linked identity and purity evidence suitable for a small molecule. HPLC can describe chromatographic purity, while LC-MS or MS can support molecular identity; NMR or other orthogonal evidence may be appropriate for structure confirmation depending on the supplier and material. Review sample ID, expected and observed molecular information, complete chromatogram, integration, method reference, dates, report number and authorization. A single HPLC percentage cannot prove chemical identity, exact content, residual-solvent control or every possible impurity.

Separate assay, chromatographic purity and vial content

Define independent acceptance fields for chemical identity, chromatographic purity, assay or quantitative content, water where relevant and finished-vial amount. Ask what method or controlled filling record supports the 50mg label and what tolerance applies. Confirm whether the amount represents net AICAR or total lyophilized material including water, counterions or excipients. Obtain reconciliation of bulk material issued, units filled, rejects and retained quantities where applicable. A favorable purity result must not be used as a substitute for quantitative content.

Control documentation, labels and recurring wholesale supply

Approve labels showing AICAR or Acadesine, strength, lot and RUO wording. Map the legal seller, synthesis site, laboratory, filling site, release authority, inventory owner and shipper. Confirm released stock, MOQ, production and testing lead time, document-approval timing, packaging and change notification. Require the batch COA, analytical attachments, SDS, specification, labels, invoice and packing list to agree. Reassess every new lot and base repeat-order approval on actual document accuracy, delivery, packaging and corrective response.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• AICAR 50mg
• MOTS-c Supplier Guide
• Third-Party Testing Guide

Frequently asked questions